Tianjin Zhongxin Pharmaceutical Group Corp Ltd Cash Flow Quality Index
Tianjin Zhongxin Pharmaceutical Group Corp Ltd cash flow quality index. Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329) has a Cash Flow Quality Index of 0.49x as of September 2025. Operating cash flow of CN¥110.78 Million is below net income of CN¥224.56 Million, suggesting accrual-heavy earnings not yet converted to cash. See Tianjin Zhongxin Pharmaceutical Group Co (600329) financial flexibility to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Tianjin Zhongxin Pharmaceutical Group Corp Ltd (2001–2024)
Cash flow quality index of Tianjin Zhongxin Pharmaceutical Group Corp Ltd from 2001 to 2024. Historical Cash Flow Quality Index for Tianjin Zhongxin Pharmaceutical Group Corp Ltd across 22 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore 600329 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Tianjin Zhongxin Pharmaceutical Group Corp Ltd Cash Flow Quality Index by Year (2001–2024)
Tianjin Zhongxin Pharmaceutical Group Corp Ltd cash flow quality index by year from 2001 to 2024. Year-by-year earnings quality comparison for Tianjin Zhongxin Pharmaceutical Group Corp Ltd. For the full cash flow conversion analysis, see Tianjin Zhongxin Pharmaceutical Group Co (600329) cash conversion ratio.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.42x | CN¥924.67 Million | CN¥2.22 Billion | ▼ -41.3% |
| 2023 | 0.71x | CN¥688.49 Million | CN¥968.71 Million | ▼ -8.4% |
| 2022 | 0.78x | CN¥677.25 Million | CN¥873.26 Million | ▼ -28.4% |
| 2021 | 1.08x | CN¥852.40 Million | CN¥786.88 Million | ▲ +9.7% |
| 2020 | 0.99x | CN¥671.42 Million | CN¥679.66 Million | ▲ +26.7% |
| 2019 | 0.78x | CN¥495.49 Million | CN¥635.36 Million | ▲ +26.5% |
| 2018 | 0.62x | CN¥350.14 Million | CN¥567.79 Million | ▲ +7446.5% |
| 2017 | -0.01x | CN¥-3.97 Million | CN¥473.26 Million | ▼ -100.8% |
| 2016 | 1.03x | CN¥419.90 Million | CN¥407.61 Million | ▲ +30.8% |
| 2015 | 0.79x | CN¥360.58 Million | CN¥457.87 Million | ▲ +4.2% |
| 2014 | 0.76x | CN¥286.85 Million | CN¥379.44 Million | ▲ +27.7% |
| 2013 | 0.59x | CN¥213.44 Million | CN¥360.59 Million | ▲ +1203.6% |
| 2012 | 0.05x | CN¥20.81 Million | CN¥458.29 Million | ▼ -93.0% |
| 2011 | 0.65x | CN¥173.88 Million | CN¥266.59 Million | ▲ +50.5% |
| 2010 | 0.43x | CN¥139.04 Million | CN¥320.84 Million | ▲ +42.8% |
| 2009 | 0.30x | CN¥83.41 Million | CN¥274.91 Million | ▼ -61.4% |
| 2008 | 0.79x | CN¥155.77 Million | CN¥198.22 Million | ▼ -72.0% |
| 2005 | 2.81x | CN¥261.91 Million | CN¥93.21 Million | ▲ +2146.3% |
| 2004 | 0.13x | CN¥10.50 Million | CN¥83.91 Million | ▼ -82.8% |
| 2003 | 0.73x | CN¥76.57 Million | CN¥105.15 Million | ▼ -63.5% |
| 2002 | 2.00x | CN¥187.60 Million | CN¥93.98 Million | ▼ -6.8% |
| 2001 | 2.14x | CN¥157.73 Million | CN¥73.65 Million | — |